Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Treatment of psychotic symptoms in patients with Parkinson disease.

Chen JJ.

Ment Health Clin. 2018 Mar 23;7(6):262-270. doi: 10.9740/mhc.2017.11.262. eCollection 2017 Nov.

2.

Focus on aggressive behaviour in mental illness.

Pompili E, Carlone C, Silvestrini C, Nicolò G.

Riv Psichiatr. 2017 Sep-Oct;52(5):175-179. doi: 10.1708/2801.28344. Review.

PMID:
29105699
3.

VPS35-Related Parkinson Disease.

Deutschländer A, Ross OA, Wszolek ZK.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2017 Aug 10.

4.

Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms.

Peitl V, Štefanović M, Karlović D.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:209-215. doi: 10.1016/j.pnpbp.2017.04.011. Epub 2017 Apr 14.

PMID:
28416295
5.

Hyperprolinemia as a clue in the diagnosis of a patient with psychiatric manifestations.

Duarte M, Afonso J, Moreira A, Antunes D, Ferreira C, Correia H, Marques M, Sequeira S.

Brain Dev. 2017 Jun;39(6):539-541. doi: 10.1016/j.braindev.2017.01.008. Epub 2017 Feb 13.

PMID:
28202261
6.

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.

Purves-Tyson TD, Owens SJ, Rothmond DA, Halliday GM, Double KL, Stevens J, McCrossin T, Shannon Weickert C.

Transl Psychiatry. 2017 Jan 17;7(1):e1003. doi: 10.1038/tp.2016.257.

7.

PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

de Koning MB, van Duin ED, Boot E, Bloemen OJ, Bakker JA, Abel KM, van Amelsvoort TA.

Psychopharmacology (Berl). 2015 Sep;232(17):3111-22. doi: 10.1007/s00213-015-3971-5. Epub 2015 Jun 12.

PMID:
26068888
8.

Melanogenesis and antioxidant defense system in normal human melanocytes cultured in the presence of chlorpromazine.

Otreba M, Wrześniok D, Beberok A, Rok J, Buszman E.

Toxicol In Vitro. 2015 Feb;29(1):221-7.

PMID:
25449126
9.

Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.

Radoeva PD, Coman IL, Salazar CA, Gentile KL, Higgins AM, Middleton FA, Antshel KM, Fremont W, Shprintzen RJ, Morrow BE, Kates WR.

Psychiatr Genet. 2014 Dec;24(6):269-72. doi: 10.1097/YPG.0000000000000062.

10.

Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.

Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.

Behav Brain Funct. 2014 Jul 29;10:26. doi: 10.1186/1744-9081-10-26.

11.

Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.

Tybura P, Trześniowska-Drukała B, Bienkowski P, Beszlej A, Frydecka D, Mierzejewski P, Samochowiec A, Grzywacz A, Samochowiec J.

Psychiatry Res. 2014 Oct 30;219(2):261-7. doi: 10.1016/j.psychres.2014.05.039. Epub 2014 Jun 2.

PMID:
24930580
12.

Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.

Carmel M, Zarchi O, Michaelovsky E, Frisch A, Patya M, Green T, Gothelf D, Weizman A.

J Psychiatr Res. 2014 Sep;56:28-35. doi: 10.1016/j.jpsychires.2014.04.019. Epub 2014 May 9.

PMID:
24853458
13.

Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.

Godar SC, Bortolato M.

Front Behav Neurosci. 2014 Mar 6;8:71. doi: 10.3389/fnbeh.2014.00071. eCollection 2014. Review.

14.

Psychosis-proneness correlates with expression levels of dopaminergic genes.

Grant P, Gabriel F, Kuepper Y, Wielpuetz C, Hennig J.

Eur Psychiatry. 2014 Jun;29(5):304-6. doi: 10.1016/j.eurpsy.2013.12.002. Epub 2014 Mar 14.

PMID:
24630741
15.

Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.

Zarchi O, Carmel M, Avni C, Attias J, Frisch A, Michaelovsky E, Patya M, Green T, Weinberger R, Weizman A, Gothelf D.

J Psychiatr Res. 2013 Nov;47(11):1623-9. doi: 10.1016/j.jpsychires.2013.07.004. Epub 2013 Aug 1.

PMID:
23910792
16.

[Functional polymorphism of genes inactivating biogenic amines and cognitive deficits in paranoid schizophrenia].

Tylec A, Kucharska-Pietura K, Jeleniewicz W, Cybulski M, Czernikiewicz A.

Psychiatr Pol. 2013 Mar-Apr;47(2):197-211. Polish.

PMID:
23888755
17.

Synthesis and bioassay of a new class of furanyl-1,3,4-oxadiazole derivatives.

El Sadek MM, Hassan SY, Abdelwahab HE, Yacout GA.

Molecules. 2013 Jul 19;18(7):8550-62. doi: 10.3390/molecules18078550.

18.

Neuroimaging correlates of 22q11.2 deletion syndrome: implications for schizophrenia research.

Boot E, van Amelsvoort TA.

Curr Top Med Chem. 2012;12(21):2303-13. Review.

PMID:
23279171
19.

Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra.

Purves-Tyson TD, Handelsman DJ, Double KL, Owens SJ, Bustamante S, Weickert CS.

BMC Neurosci. 2012 Aug 6;13:95. doi: 10.1186/1471-2202-13-95.

20.

Developmental changes in human dopamine neurotransmission: cortical receptors and terminators.

Rothmond DA, Weickert CS, Webster MJ.

BMC Neurosci. 2012 Feb 15;13:18. doi: 10.1186/1471-2202-13-18.

Supplemental Content

Loading ...
Support Center